Biotech has rceived a notice of allowance from the USPTO for a patent application covering the company's long-acting CTP-enhanced human growth hormone (hGH-CTP). Once the patent is issued, PROLOR would gain additional intellectual ...
Tags: PROLOR, CTP platform, human growth hormone
Cara Therapeutics and Chong Kun Dang Pharmaceutical have signed licensing contract to develop and market CR845, an analgesic drug candidate, in the Republic of Korea. As a part of the agreement, Cara is eligible to gain an up-front ...
Tags: analgesic drug candidate, licensing contract, CR845, Cara Therapeutics